Effects of pre-eclampsia on maternal plasma, cerebrospinal fluid, and umbilical cord urotensin II concentrations: a pilot study.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  British Journal of Anaesthesia

• Publication date

  2005-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/BJA/AEI222PMID 16126783
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathophysiology of preeclampsia: links with implantation disorders.

  2004cited by this paper
• Urotensin-II and the cardiovascular system – the importance of developing modulators

  2004cited by this paper
• Plasma concentration of urotensin II is raised in hypertension

  2004cited by this paper
• Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries.

  2004cited by this paper
• Urotensin II: the old kid in town.

  2004cited by this paper
• Urotensin II, a novel peptide in central and peripheral cardiovascular control.

  2004cited by this paper
• From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function.

  2004cited by this paper
• Urotensin-II as a novel therapeutic target in the clinical management of cardiorenal disease.

  2004cited by this paper
• [Clinical study of changes of urotensin II in patients with congestive heart failure].

  2003cited by this paper
• The diagnosis and management of pre‐eclampsia

  2003cited by this paper
• Urotensin II Acts Centrally to Increase Epinephrine and ACTH Release and Cause Potent Inotropic and Chronotropic Actions

  2003cited by this paper
• Increased plasma urotensin II levels in patients with diabetes mellitus.

  2003cited by this paper
• Human urotensin-II as a novel cardiovascular target: 'heart' of the matter or simply a fishy 'tail'?

  2003cited by this paper
• A Comparison of Cerebrospinal Fluid and Plasma Urotensin II Concentrations in Normotensive and Hypertensive Patients Undergoing Urological Surgery During Spinal Anesthesia: A Pilot Study

  2003cited by this paper
• Is urotensin‐II the new endothelin?

  2002cited by this paper
• Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure.

  2002cited by this paper
• Plasma Urotensin in Human Systolic Heart Failure

  2002cited by this paper
• Production of vasoactive substances by human umbilical vein endothelial cells after incubation with serum from preeclamptic patients.

  2001cited by this paper
• Role of urotensin II in patients on dialysis.

  2001cited by this paper
• Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension.

  2001cited by this paper
• The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)

  2001cited by this paper
• Urotensin II: fish neuropeptide catches orphan receptor.

  2000cited by this paper
• Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease.

  2000cited by this paper
• Recent developments in the pathophysiology and management of pre-eclampsia.

  1996cited by this paper
• A reference preparation for the study of active substances in the caudal neurosecretory system of teleosts.

  1969cited by this paper

• Decreased PPP1R3G in pre-eclampsia impairs human trophoblast invasion and migration via Akt/MMP-9 signaling pathway

  2023cites this paper
• Plasma Urotensin II Concentration In Gestational Diabetes

  2017influential citation
• Elevated levels of protein AMBP in cerebrospinal fluid of women with preeclampsia compared to normotensive pregnant women

  2017cites this paper
• Expression levels of urotensin II are associated with endoplasmic reticulum stress in patients with severe preeclampsia

  2016cites this paper
• International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II–Related Peptide, and Their Receptor: From Structure to Function

  2015cites this paper
• Signaling switch of the urotensin II vasosactive peptide GPCR: prototypic chemotaxic mechanism in glioma

  2015cites this paper
• The Importence of Urotensin and Urotensin Receptors in Cardiovascular System

  2014cites this paper
• Study of urotensin II gene and serum levels in relation to pre-eclampsia.

  2014cites this paper
• Urotensin‐II 143 G/A Polymorphism is not Associated with the Risk of Preeclampsia in Korean Women

  2011cites this paper
• Association between urotensin II gene polymorphism and pre-eclampsia.

  2010cites this paper
• Upregulation of Urotensin II Receptor in Preeclampsia Causes In Vitro Placental Release of Soluble Vascular Endothelial Growth Factor Receptor 1 in Hypoxia

  2010cites this paper
• Nociceptin and urotensin-II concentrations in critically ill patients with sepsis.

  2008cites this paper
• The Urotensin II System in Ischaemic Myocardial Dysfunction.

  2008cites this paper
• Urotensin II: from osmoregulation in fish to cardiovascular regulation in man.

  2007cites this paper
• Role of urotensin II and its receptor in health and disease

  2007cites this paper
• Does cigarette smoking increase plasma urotensin II concentrations?

  2007cites this paper
• Urotensin-II and cardiovascular diseases

  2006cites this paper
• The role of urotensin II in cardiovascular and renal physiology and diseases

  2006cites this paper
• Urotensin II and cardiovascular diseases.

  2004cites this paper